EnGeneIC Employee Directory
Biotechnology ResearchNew South Wales, Australia51-200 Employees
EnGeneIC is an Australia-based biopharmaceutical company focused on advancing its EDV nanocell platform, which is designed to deliver chemotherapy drugs and functional nucleic acids directly to cancer cells. The EDV platform is described as a first-in-class Cyto-Immunotherapy system. Located in North Ryde, New South Wales, the company operates within the biotechnology research sector as a mid-sized organization developing targeted cancer therapies. Its customers include other biopharma developers and research institutions seeking advanced delivery technologies to improve cancer treatment outcomes, with collaborations aimed at manufacturing and advancing EDV-based therapies. In June 2026, EnGeneIC was honored with the Breakthrough in glioblastoma Biotech Award at a Northwell Foundation gala in New York, highlighting recognition of its work in glioblastoma applications.